Generating decision-ready real-world evidence to support HTA, regulatory, reimbursement, and evidence-generation decisions across global and local settings.

• Data source identification and feasibility assessment, including registries, claims databases, electronic health records, and federated data networks.
• Robust RWE study design, from research question refinement to protocol development and statistical analysis planning.
• Real-world evidence analysis and interpretation, using federated or direct data access routes to address evidence gaps across clinical outcomes, safety, care pathways, resource use, and economic model inputs, with findings translated into decision-ready insights.